For citations:
ZILTSOVA E.K., IVANOVA O.A., KRIVOROTKO P.V., IVANOV V.G., CYRLINA E.V., DASHYAN G.A., TABAGUA T.T., NIKOLAEV K.S., GIGOLAEVA L.P., SEMIGLAZOV V.F. Can the androgen receptor blocking become the basis of a new method of treatment of triple negative breast cancer? Malignant tumours. 2017;(1):18-25. (In Russ.) https://doi.org/10.18027/2224-5057-2017-1-18-25
Email this article 